Current safety data for 5-amino-1MQ appears favorable for short-term use (8-12 week cycles), with no significant toxicity observed in preclinical studies at therapeutic doses
Cloudy solution can mean degradation or contamination
We could supply 13 API products (Ivermectin, Eprinomectin, Tiamulin Hydrogen Fumarate, Abamectin, Oxytetracycline HCL, Tilmicosin, Tilmicosin Phosphate, Florfenicol, Doxycycline HCL, Tylvalosin Tartrate, Tildipirosin, Valnemulin HCL), and 12 dosage forms including injection, oral solution, powder, premix, pulvis, granule, bolus/tablet, pouring on solution, injectable powder, pesticides and disinfectant, ects
Key Benefits Rapid Bioavailability Intramuscular or slow IV administration bypasses gastrointestinal limits for immediate plasma levels